Intrahepatic innate lymphoid cells secrete IL-17A and IL-17F that are crucial for T cell priming in viral infection.
Intrahepatic innate lymphoid cells secrete IL-17A and IL-17F that are crucial for T cell priming in viral infection.
复制标题
DOI:
10.4049/jimmunol.1303281
复制
发表时间:
2014-04-01
期刊:
影响因子:
--
通讯作者:
Sun J
中科院分区:
文献类型:
--
作者:
Jie Z;Liang Y;Hou L;Dong C;Iwakura Y;Soong L;Cong Y;Sun J
Intrahepatic cell-derived, early IL-17 is important for activating antigen-presenting cells in viral infection; however, the source and regulation of this IL-17 surge in the liver microenvironment are not well defined. Here, we present evidence for a significant expansion of IL-17A/F-producing cells in mouse liver within 24 h of adenovirus (Ad) infection. In addition to λδ T cells, a subset of IL-17A/F+ cells expressed no myeloid or lymphoid lineage markers. Instead, they expressed high levels of stem cell markers, IL-7 receptor and RORλt, consistent with the newly described innate lymphoid cells. Based on their unique surface markers and cytokine profiles, these cells were confirmed as group 3 innate lymphoid cells (ILC3s). In addition to Ad infection, ILC3s were also found in mouse liver within 24 h of LCMV infection. They contributed significantly to the establishment of the early cytokine milieu in virus-infected liver. Functional studies with mice deficient of IL-17 receptor, IL-17A, and IL-17F further revealed that IL-17 signaling was critical for priming T cell responses in viral hepatitis. IL-17A repressed IL-17F secretion in vitro and in vivo; IL-17F+ intrahepatic cells expanded more vigorously in IL-17A knockout animals, permitting efficient antigen-presentation and T cell function. However, IL-17F neither inhibited IL-17A in vitro, nor regulated its secretion in vivo. Together, this study has demonstrated the importance of a unique intrahepatic subpopulation and subsequent IL-17A/F regulation at initial stages of viral infection in the liver. These results have important implications for anti-cytokine biologic therapy and vaccine development.
登录
查看更多内容
影响因子:
15.9
作者:
Haak, Stefan;Croxford, Andrew L.;Waisman, Ari
通讯作者:
Waisman, Ari
影响因子:
13.5
作者:
KNODELL, RG;ISHAK, KG;WOLLMAN, J
通讯作者:
WOLLMAN, J
DOI:
10.1111/j.1600-6143.2011.03458.x
发表时间:
2011-04
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
Basha HI;Subramanian V;Seetharam A;Nath DS;Ramachandran S;Anderson CD;Shenoy S;Chapman WC;Crippin JS;Mohanakumar T
通讯作者:
Mohanakumar T
影响因子:
24.1
作者:
通讯作者:
--
影响因子:
32.4
作者:
McHedlidze T;Waldner M;Zopf S;Walker J;Rankin AL;Schuchmann M;Voehringer D;McKenzie AN;Neurath MF;Pflanz S;Wirtz S
通讯作者:
Wirtz S